Evaluation and management of the patient with pulmonary arterial hypertension.
about
Right ventricular adaptation and failure in pulmonary arterial hypertension.Etiopathogenetic mechanisms of pulmonary hypertension in sleep-related breathing disorders.Association of African American race with elevated pulmonary artery diastolic pressure: data from the Heart and Soul Study.Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction.Riociguat (BAY 63-2521) and warfarin: a pharmacodynamic and pharmacokinetic interaction study.New approaches to the treatment of pulmonary hypertension: from bench to bedside.A patient with severe pulmonary hypertension for hip arthroplastyComprehensive Multi-Dimensional MRI for the Simultaneous Assessment of Cardiopulmonary Anatomy and Physiology.Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel reportThe angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.Associated pulmonary arterial hypertension in connective tissue diseases.Midterm results of "treat and repair" for adults with non-restrictive ventricular septal defect and severe pulmonary hypertension.A review of pulmonary arterial hypertension: role of ambrisentan.Cocaine enhances HIV-1 gp120-induced lymphatic endothelial dysfunction in the lung.Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.Combination drug therapy in the management of pulmonary arterial hypertension.Treatment of pulmonary hypertensionIsolated pulmonary veno-occlusive disease and pulmonary arterial thrombosis in systemic sclerosis - a lethal combination.Pulmonary hypertension: clinical manifestations, classification and diagnosis.Phenotypes of chronic obstructive pulmonary disease.Treatment options for transposition of the great arteries with ventricular septal defect complicated by pulmonary vascular obstructive disease.Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer.Genetics of systemic sclerosis-associated pulmonary arterial hypertension: recent progress and current concepts.Effect of early administration of lower dose versus high dose of fresh mitochondria on reducing monocrotaline-induced pulmonary artery hypertension in rat.Pulmonary arterial hypertension in human immunodeficiency virus infection.Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.Tadalafil: in pulmonary arterial hypertension.Role of combination therapy in the treatment of pulmonary arterial hypertension.Essential echocardiographic evaluation in patients with suspected pulmonary hypertension: an overview for the practicing physician.Pulmonary endarterectomy for the treatment of chronic thromboembolic pulmonary hypertension.Underlying aetiology of pulmonary hypertension in 191 patients: a single centre experience.Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus.Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension.Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism.Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension.Normal range of mechanical variables in pulmonary hypertension: a tissue Doppler imaging study.Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.Idiopathic pulmonary arterial hypertension misdiagnosed as asthma.
P2860
Q27318422-451E44BA-AF27-4F63-9889-E93FAFF82FD0Q30419870-1126ABFD-EED8-4F2C-BE5E-E34EC7237329Q31116704-7C75A985-732A-487C-86C0-81A9417D5EF1Q33166775-AB696FA3-E142-40F1-8D37-39A0C920D061Q33447738-96CD6858-2A69-4048-AC3B-297CAC2D2797Q33690368-E5FCDB77-E320-499A-BB48-38C332ED9B12Q33808583-F22E46FB-9183-4D1F-BC37-C34CA74848AEQ33903211-D811ACB0-B3C1-4231-AFEC-EDDEFE0EA351Q34064492-F2A01AF1-E6E8-4F89-8C64-F77BE3B7374BQ34268946-A515A08D-EB92-4066-AB87-3DE6860690E6Q35617799-FEC0856A-7F7A-466B-A76B-B8EE0A40CB7DQ35909315-BC055C6A-51AC-4552-BF32-28F369BDC668Q36013161-62DEC3A1-524F-41F0-AC73-F7DC37AD4F07Q36036429-AC16E4D9-B890-4C16-A593-0FD1473969AEQ36075442-96A5BC39-52A5-4D0C-BC1A-A15EA08C4645Q36308694-00B5342B-3B8A-44A3-927E-CDD47A6AC774Q36577681-CE7056F0-818C-4A0C-ACCC-1565D386C3B9Q36856521-75344180-22A0-4FDB-AA66-F32CBB226E4FQ36896631-D70337E1-ABE7-470C-92C2-5EBE12FFBE70Q37008634-0B49C0A5-A19C-4349-BCA5-82B3FC8A6E56Q37055630-32407715-7224-40F8-B499-8C3DF012085BQ37070077-16483CED-F0E5-45FE-B853-CCB28F10A0E3Q37319058-6B7D56F4-3DB5-4035-AF24-C33D988AAF18Q37417751-DA882CEE-484C-4A8B-AF11-6EC9C4B81D93Q37553700-56FBD7E1-E156-411E-9703-D1A57C4753F1Q37612691-1D643656-FDEA-427C-8EA9-EEE1D5CB9DE9Q37656327-E328DABC-48F5-4573-B703-6DA9FCAB8233Q37703200-7256E6D8-8E1D-4A4A-B295-4119A39B40CBQ37718231-1BFF7225-01A4-4CF3-8EE1-CB00303ED68CQ38631423-2C6D2CAC-08E7-4261-9369-AC965DAFE77DQ38806131-7692A903-B4F1-48F9-A98E-DEBBA97A522AQ40043643-60207625-7142-4DFE-A278-477D59215A65Q41888223-451020A6-D25B-487A-BD71-AAFD157B0F62Q42183063-E32B3386-4FFA-48A9-ADFD-0DF87D66EF35Q42284467-143ADEC2-F3A5-4645-B773-49281F20FAD1Q46222874-1FADB463-6818-4FC7-9968-1963A08DF3C5Q46503970-BAD8F213-2C88-460F-9441-6CB4F3B9F0C9Q48722884-F54CEF51-490B-4411-8207-2B301172BEF9Q51760986-BDDFC9EA-C689-4DA4-8701-6EF1EFB3CDA5
P2860
Evaluation and management of the patient with pulmonary arterial hypertension.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Evaluation and management of the patient with pulmonary arterial hypertension.
@ast
Evaluation and management of the patient with pulmonary arterial hypertension.
@en
Evaluation and management of the patient with pulmonary arterial hypertension.
@nl
type
label
Evaluation and management of the patient with pulmonary arterial hypertension.
@ast
Evaluation and management of the patient with pulmonary arterial hypertension.
@en
Evaluation and management of the patient with pulmonary arterial hypertension.
@nl
prefLabel
Evaluation and management of the patient with pulmonary arterial hypertension.
@ast
Evaluation and management of the patient with pulmonary arterial hypertension.
@en
Evaluation and management of the patient with pulmonary arterial hypertension.
@nl
P1476
Evaluation and management of the patient with pulmonary arterial hypertension.
@en
P2093
David B Badesch
Lewis J Rubin
P304
P356
10.7326/0003-4819-143-4-200508160-00009
P407
P577
2005-08-01T00:00:00Z